Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (101-110 of 319) with videos related to

Pageof 32
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|July 3, 2002
Measurement of body fat by dual-energy X-ray absorptiometry and bioimpedance analysis in men with prostate cancerMatthew R Smith, Vanessa Fuchs, Ellen J Anderson, et al.
Plos One|April 12, 2017
Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakesTy Beal, Eric Massiot, Joanne E Arsenault, et al.
Magnetic Resonance in Medicine|December 9, 2014
Characterizing the limits of MRI near metallic prosthesesMatthew R Smith, Nathan S Artz, Curtis Wiens, et al.
Clinical Advances in Hematology & Oncology : H&O|September 11, 2009
New opportunities for the management of cancer-related bone complicationsAllan Lipton, Gordon A Brown, Gregory R Mundy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancerEric J Small, Matthew R Smith, John J Seaman, et al.
Magnetic Resonance in Medicine|January 17, 2014
Accelerating sequences in the presence of metal by exploiting the spatial distribution of off-resonanceMatthew R Smith, Nathan S Artz, Kevin M Koch, et al.
The Journal of Urology|September 28, 2011
Gonadotropin-releasing hormone blockers and cardiovascular disease risk: analysis of prospective clinical trials of degarelixMatthew R Smith, Laurence Klotz, Egbert van der Meulen, et al.
Cancer|June 8, 2013
Ultraviolet index and racial differences in prostate cancer incidence and mortalityGlen B Taksler, David M Cutler, Edward Giovannucci, et al.
The Journal of Urology|May 29, 2003
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancerMatthew R Smith, James Eastham, Donald M Gleason, et al.
Cancer|June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancerM Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Pageof 32

Showing results (101-110 of 319) with videos related to

Sort By:
Pageof 32
Nutrition (Burbank, Los Angeles County, Calif.)|July 3, 2002
Measurement of body fat by dual-energy X-ray absorptiometry and bioimpedance analysis in men with prostate cancerMatthew R Smith, Vanessa Fuchs, Ellen J Anderson, et al.
Plos One|April 12, 2017
Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakesTy Beal, Eric Massiot, Joanne E Arsenault, et al.
Magnetic Resonance in Medicine|December 9, 2014
Characterizing the limits of MRI near metallic prosthesesMatthew R Smith, Nathan S Artz, Curtis Wiens, et al.
Clinical Advances in Hematology & Oncology : H&O|September 11, 2009
New opportunities for the management of cancer-related bone complicationsAllan Lipton, Gordon A Brown, Gregory R Mundy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancerEric J Small, Matthew R Smith, John J Seaman, et al.
Magnetic Resonance in Medicine|January 17, 2014
Accelerating sequences in the presence of metal by exploiting the spatial distribution of off-resonanceMatthew R Smith, Nathan S Artz, Kevin M Koch, et al.
The Journal of Urology|September 28, 2011
Gonadotropin-releasing hormone blockers and cardiovascular disease risk: analysis of prospective clinical trials of degarelixMatthew R Smith, Laurence Klotz, Egbert van der Meulen, et al.
Cancer|June 8, 2013
Ultraviolet index and racial differences in prostate cancer incidence and mortalityGlen B Taksler, David M Cutler, Edward Giovannucci, et al.
The Journal of Urology|May 29, 2003
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancerMatthew R Smith, James Eastham, Donald M Gleason, et al.
Cancer|June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancerM Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Pageof 32